NanoVision Diagnostics

LEADERSHIP

Michael Lang, Founder and CEOMichael Lang, Founder and CEO - Michael Lang is an experienced CEO and a medical device entrepreneur. He has led development and commercialization of many minimally invasive therapies and novel biomaterials. Michael has degrees in Biomedical Engineering and an MBA. He brings extensive experience in product development, marketing, general management, strategic business development, venture finance and fundraising. He was formerly president of Galt Medical, Vice president of Business development at BioEnterprise and Division General Manager at Avery Dennison.  Previously Michael held engineering and marketing roles at Bard, Johnson and Johnson and Gliatech.  

 

 

 

 


Bernie Hete, Ph.D.Bernard Hete, PhD, Founder and Vice President, Research and Development – Dr. Hete is a scientist, engineer and medical devices entrepreneur. He has developed multiple novel health care products and has extensive expertise in product development electronics, mathematical systems modeling, algorithm development and clinical research. Bernie has a PhD in Biomedical Engineering. Previously he was VP of R&D and co-founder of Starr Life Sciences and Sr. Scientist at Respironics Division of Philips.


 

 


CLINICAL ADVISOR

Bernie Hete, Ph.D.Paul Kornblith, M.D. - Dr. Paul Kornblith is a world renowned neurosurgeon, cancer researcher and entrepreneur.  He is founder and former CEO of Precision Therapeutics, Inc., Director of Western Pennsylvania for PA-BIO, medical advisor to Pittsburgh Life Sciences Greenhouse and medical advisor and board member for numerous companies.  Dr. Kornblith received his MD from Jefferson Medical College and completed his neurosurgery residency and fellowship at Massachusetts General Hospital. He was chief of Neurosurgery at NIH and vice chairman of neurosurgery at University of Pittsburgh Medical Center. He has authored 140 peer reviewed publication and numerous books and book chapters.